FDA DEVICE FACTS
TREO® Abdominal Stent-Graft System
Bolton Medical, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The TREO® Abdominal Stent-Graft System is indicated for use in the endovascular treatment of patients with infrarenal abdominal aortic and aorto- iliac aneurysms with the following characteristics:
• Adequate iliac or femoral access compatible with the required delivery systems and accessories
• Proximal aortic landing zone with: o Infrarenal landing neck length of ≥ 15mm o Aortic neck diameters ≥ 17 mm and ≤ 32 mm o Suprarenal neck angle of ≤ 45 degrees o Infrarenal neck angle of ≤ 60 degrees
• Distal iliac landing zone with: o an inside diameter of 8 mm – 13 mm and a length of ≥ 10 mm or o an inside diameter of > 13 mm – 20 mm and a length of ≥ 15 mm
• Minimum overall AAA treatment length (proximal landing location to distal landing location) of 13 cm
• Minimum overall length from the lowest renal artery to the aortic bifurcation of 9 cm
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。